Cargando…

The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi

BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gyne...

Descripción completa

Detalles Bibliográficos
Autores principales: Singano, Victor, Amberbir, Alemayehu, Garone, Daniela, Kandionamaso, Christopher, Msonko, Jack, van Lettow, Monique, Kalima, Kondwani, Mataka, Yamikani, Kawalazira, Gift, Mateyu, Gabriel, Kwekwesa, Aunex, Matengeni, Alfred, van Oosterhout, Joep J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695797/
https://www.ncbi.nlm.nih.gov/pubmed/29155891
http://dx.doi.org/10.1371/journal.pone.0188379
_version_ 1783280362758078464
author Singano, Victor
Amberbir, Alemayehu
Garone, Daniela
Kandionamaso, Christopher
Msonko, Jack
van Lettow, Monique
Kalima, Kondwani
Mataka, Yamikani
Kawalazira, Gift
Mateyu, Gabriel
Kwekwesa, Aunex
Matengeni, Alfred
van Oosterhout, Joep J.
author_facet Singano, Victor
Amberbir, Alemayehu
Garone, Daniela
Kandionamaso, Christopher
Msonko, Jack
van Lettow, Monique
Kalima, Kondwani
Mataka, Yamikani
Kawalazira, Gift
Mateyu, Gabriel
Kwekwesa, Aunex
Matengeni, Alfred
van Oosterhout, Joep J.
author_sort Singano, Victor
collection PubMed
description BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. METHODS: We conducted a cross–sectional study in males ≥18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. RESULTS: We enrolled 1,027 men with median age 44 years (IQR: 38–52). The median ART duration was 57 months (IQR: 27–85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7–7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2–7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04–4.25). CONCLUSIONS: The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management.
format Online
Article
Text
id pubmed-5695797
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56957972017-11-30 The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi Singano, Victor Amberbir, Alemayehu Garone, Daniela Kandionamaso, Christopher Msonko, Jack van Lettow, Monique Kalima, Kondwani Mataka, Yamikani Kawalazira, Gift Mateyu, Gabriel Kwekwesa, Aunex Matengeni, Alfred van Oosterhout, Joep J. PLoS One Research Article BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. METHODS: We conducted a cross–sectional study in males ≥18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. RESULTS: We enrolled 1,027 men with median age 44 years (IQR: 38–52). The median ART duration was 57 months (IQR: 27–85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7–7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2–7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04–4.25). CONCLUSIONS: The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management. Public Library of Science 2017-11-20 /pmc/articles/PMC5695797/ /pubmed/29155891 http://dx.doi.org/10.1371/journal.pone.0188379 Text en © 2017 Singano et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Singano, Victor
Amberbir, Alemayehu
Garone, Daniela
Kandionamaso, Christopher
Msonko, Jack
van Lettow, Monique
Kalima, Kondwani
Mataka, Yamikani
Kawalazira, Gift
Mateyu, Gabriel
Kwekwesa, Aunex
Matengeni, Alfred
van Oosterhout, Joep J.
The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title_full The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title_fullStr The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title_full_unstemmed The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title_short The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
title_sort burden of gynecomastia among men on antiretroviral therapy in zomba, malawi
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695797/
https://www.ncbi.nlm.nih.gov/pubmed/29155891
http://dx.doi.org/10.1371/journal.pone.0188379
work_keys_str_mv AT singanovictor theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT amberbiralemayehu theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT garonedaniela theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kandionamasochristopher theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT msonkojack theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT vanlettowmonique theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kalimakondwani theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT matakayamikani theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kawalaziragift theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT mateyugabriel theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kwekwesaaunex theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT matengenialfred theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT vanoosterhoutjoepj theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT singanovictor burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT amberbiralemayehu burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT garonedaniela burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kandionamasochristopher burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT msonkojack burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT vanlettowmonique burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kalimakondwani burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT matakayamikani burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kawalaziragift burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT mateyugabriel burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT kwekwesaaunex burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT matengenialfred burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi
AT vanoosterhoutjoepj burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi